Kirby McInerney LLP | Financial Litigation Law Firm | <b ><span >Lizhi Inc.</span ></b >
This links to the home page
Cases
PRACTICE AREAS

Lizhi Inc.


The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Lizhi Inc. (“Lizhi” or the “Company”) (NASDAQ: LIZI) securities American Depositary Shares (“ADSs” or “shares”) pursuant and/or traceable to the Company’s January 2020 initial public offering (“IPO” of the “Offering”). Investors have until March 22, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The complaint alleges that Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) at the time of the IPO, the coronavirus was already ravaging China, the home base, principal market, and significant hub for Lizhi, its employees, and its customers; (2) the complications associated with the coronavirus were already negatively affecting Lizhi’s business, as employees and customers contracted the virus, lost employment, or otherwise experienced difficulty in generating, publishing, and monetizing the content critical to Lizhi’s platform; (3) even prior to the IPO, Lizhi employees and customers complained of, and to, Lizhi, which harmed the Company’s reputation and financial condition and prospects; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
 
In January, 2020, Lizhi conducted its IPO, issuing 4.1 million ADSs priced at $11.00 per ADS. On April 20, 2020, Lizhi admitted that before the IPO, as early as “late 2019,” the COVID-19 pandemic was already negatively impacting its business. Since the IPO, Lizhi shares are trading below $4 per share, or 63% below the IPO price.
If you purchased or otherwise acquired Lizhi securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.
 

Lizhi Inc. Investor Contact Form